These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 2539403)

  • 1. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD; Katz R; Sullivan JM; Wolfson P; Haugland M; Kirlin P; Powers E; Rich S; Hackshaw B; Chiaramida A
    J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril.
    Morisco C; Condorelli M; Crepaldi G; Rizzon P; Zardini P; Villa G; Argenziano L; Trimarco B
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):63-9. PubMed ID: 9140680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
    Powers ER; Chiaramida A; DeMaria AN; Giles TD; Hackshaw B; Hart W; Haugland M; Johnston R; Katz R; Kirlin P
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S82-8. PubMed ID: 2442559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lisinopril versus placebo for congestive heart failure.
    Lewis GR
    Am J Cardiol; 1989 Feb; 63(8):12D-16D. PubMed ID: 2537560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study.
    Chalmers JP; West MJ; Cyran J; De La Torre D; Englert M; Kramar M; Lewis GR; Maranhao MF; Myburgh DP; Schuster P
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S89-97. PubMed ID: 2442560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
    Giles TD
    Z Kardiol; 1991; 80 Suppl 2():35-9. PubMed ID: 1850941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure.
    Bach R; Zardini P
    Am J Cardiol; 1992 Oct; 70(10):70C-77C. PubMed ID: 1329477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with lisinopril in congestive heart failure. Focus on the older patient.
    Giles TD
    Drugs; 1990; 39 Suppl 2():17-22. PubMed ID: 2160883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisinopril versus placebo in older congestive heart failure patients.
    Lewis GR
    Am J Med; 1988 Sep; 85(3B):48-54. PubMed ID: 2844088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of lysinopril in cardiac insufficiency].
    Lambert M; Luccioni R
    Rev Prat; 1990 Oct; 40(23 Suppl):53-8. PubMed ID: 2176346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study Group.
    Beller B; Bulle T; Bourge RC; Colfer H; Fowles RE; Giles TD; Grover J; Whipple JP; Fisher MB; Jessup M
    J Clin Pharmacol; 1995 Jul; 35(7):673-80. PubMed ID: 7560247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure.
    Feinstein AR; Fisher MB; Pigeon JG
    Am J Cardiol; 1989 Jul; 64(1):50-5. PubMed ID: 2545092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
    Dunselman PH;
    Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
    van den Broek SA; de Graeff PA; van Veldhuisen DJ; van Gilst WH; Hillege H; Wesseling H; Lie KI
    J Card Fail; 1997 Sep; 3(3):165-71. PubMed ID: 9330124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.